Maximilien Grandclaudon

Maximilien Grandclaudon is a seasoned expert in preclinical and translational therapeutic research, currently serving as Director of Preclinical & Translational Therapeutic Research at Owkin since August 2023. Prior to this role, Maximilien held positions including Principal Scientist - In-licensing at AQEMIA, and Senior Scientist - Team leader at Generate Biomedicines, where responsibilities included leading optimization efforts in drug development. Earlier experience encompasses significant contributions as a Postdoctoral Researcher at prestigious institutions, such as Dana-Farber Cancer Institute, focusing on novel immune-colorectal organoid models, and Servier, where Maximilien developed preclinical models for evaluating immune checkpoint therapies. Academic qualifications include a Research Doctorate in Immunology from Université Paris-Saclay and a Master 2 in Immunology from Pierre and Marie Curie University.